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Impact of chronologic age in the elderly with gastric 
cancer
Sung Ryol Lee, Hyung Ook Kim, Chang Hak Yoo
Department of Surgery, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea
Purpose: Although the incidence of gastric cancer has declined in the general population, it is the second most frequent cause 
of death due to malignancy in the world with its incidence in the elderly increasing as a result of increased life expectancy. 
This present study tried to find the optimal treatment for patients aged 75 years or older with gastric cancer through compar-
ison of the clinicopathological characteristics, surgical outcomes, and identifying prognostic factors of survival. Methods: 
Elderly patients who underwent gastric resection for gastric cancer from January, 1999 to February, 2009 (n = 470) were div-
ided into two groups: very elderly patients, 75 years or older (n = 95), and younger elderly patients, between 65 and 74 years 
old (n = 365). Results: Distinct characteristics of very elderly patients included more frequent underlying disease, deeper in-
vasion, and more frequent lymph node metastasis. There were significant differences in overall survival between the two 
groups at stages III-B and IV. However, postoperative hospital stays, postoperative morbidity, mortality and early stage did 
not differ between curatively resected patients in the two groups. Conclusion: Due to improved postoperative care, gas-
trectomy of gastric cancer is the treatment of choice in very elderly patients. Therefore, early diagnosis through regular medi-
cal screening and curative gastrectomy with lymph node dissection should be performed in very elderly gastric cancer 
patients.
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INTRODUCTION
Gastric cancer is one of the most common cancers in the 
world. Curative treatment of stomach cancer requires gas-
tric resection [1], and surgical approaches to treat poten-
tially curable gastric cancers, including extended lympha-
denectomy, yield better results than less radical proce-
dures [2]. The World Health Organization defines people 
65-and-over as senior citizens. Globally, the number of 
people in this age group is increasing at an unprecedented 
rate, and most of this increase is occurring in developed 
countries [3,4]. Although the incidence of gastric cancer 
has declined in the general population, it is the second 
most frequent cause of death due to malignancy in the 
world, and its incidence in the elderly is increasing as a re-
sult of increased life expectancy. Elderly people are some-
times divided into the young-old (65 to 74 years), the 
old-old (75 to 84 years) and the oldest-old (85+ years) [5]. In Sung Ryol Lee, et al.
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Korea, many old-old and oldest-old persons are older than 
the age of average human life expectancy (male 76, female 
83). Although gastric surgery has become more common 
for young-old patients, surgeons often hesitate to perform 
operations on the old-old and the oldest-old patients. As 
many old-old and oldest-old patients have comorbidities, 
the risk of surgery is often higher. In some elderly patients, 
gastric cancer may not affect life expectancy because the 
patient has already some lethal comorbidity. Therefore it is 
important to evaluate clinicopathological characteristics 
and surgical outcomes, including postoperative morbid-
ity and mortality, in the old-old and oldest-old patients. 
Some studies have compared outcomes between elderly 
and young patients with gastric cancer [6,7]. However, 
gastric cancer in young patients also has distinctive 
properties. So, this present study tried to find the optimal 
treatment of patients who ages of 75 years or older with 
gastric cancer through comparison of the clinicopatho-
logical characteristics, surgical outcomes, and identifying 
prognostic factors of survival.
METHODS
A total of 470 patients with histologically confirmed pri-
mary gastric cancer who had underwent gastrectomy be-
tween January, 1999 and February, 2009 at the Department 
of Surgery were enrolled in this study. These patients in-
cluded 95 old-old and oldest-old patients (age of 75 years 
or older) and 375 young-old patients (65 to 74 years old). 
The present study defined “very elderly” patients as those 
aged 75 or older, according to criteria used in previously 
published literature [5]. Four hundred and forty-one pa-
tients underwent curative resection (86 vs. 355) and 29 pa-
tients were treated with palliative resection (9 very elderly 
patients and 20 young-old patients). Preoperative studies 
to determine the location of the tumor, macroscopic ap-
pearance, depth of invasion, and lymph node and distant 
metastasis were routinely performed using gastroscopy 
and computed tomography. The surgical procedure was 
considered curative (R0) if gross tumor tissue, including 
metastatic lymph nodes, was removed completely and the 
microscopic examination revealed no cancer cells at both 
proximal and distal margins. The procedure was consid-
ered palliative (R1 and R2) if macroscopic or microscopic 
disease was left behind. The Japanese Gastric Cancer 
Association has standardized lymph node dissection for 
gastric cancer [8]. In the present study, lymph node dis-
section (D2 or D3) was performed in accordance with the 
guidelines of the Japanese Gastric Cancer Association. All 
patients were followed up according to our standard pro-
tocol, which includes tumor markers, gastroscopy, com-
puted tomography and chest radiography. The median 
follow-up period was 28 months and data were analyzed 
with IBM SPSS ver 18.0 (IBM Co., New York, NY, USA). 
Sixteen clinicopathological variables were used for stat-
istical analysis: patient age, gender, family history of can-
cer, underlying disease, preoperative symptoms, synchro-
nous metastasis, method of operation, curability, post-
operative hospital stay, location of tumor, histological 
type, depth of invasion, lymph node metastasis, lymphatic 
invasion, venous invasion, and pathologic stage. Patient 
characteristics were compared using Fisher's exact tests, 
chi-square tests, Mann-Whitney U tests and analysis of 
variance. The Cox proportional hazards regression model 
was used to identify prognostic factors. Overall survival 
was calculated by Kaplan-Meier estimation and examined 
by log-rank tests. P-values were considered statistically 
significant at the 0.05 level.   
RESULTS
The clinicopathological features of all 470 registered 
gastric cancer patients are listed in Tables 1, 2. There were 
significant differences in gender, underlying disease, 
depth of invasion, lymph node metastasis, lymph node 
dissection, and pathological stage between the two 
groups. In very elderly patients, female gender and under-
lying disease were significantly more frequent. Among 
the pathological characteristics, depth of invasion and 
lymph node metastasis and pathological stage were high-
er among very elderly patients. In the post hoc analysis, T3 
of depth invasion (P = 0.003), N1 and N2 of lymph node 
metastasis (P = 0.036 and P = 0.013), and pathological stage 
IIIB, IV (P = 0.001 and P = 0.031) were significantly more Gastric cancer in very elderly patients
thesurgery.or.kr 213
Variable
65 ＜ Age (yr) ＜ 74
(n = 375)
75 ≤ Age (yr)
(n = 95)
P-value
Age (yr) 68.0 
(66.0-71.0)
77.0 
(76.0-80.0)
0.000
Gender 0.018
   Male 261 (69.6)    54 (56.8)
   Female 114 (30.4)    41 (43.2)
Family history of cancer 
  Presence 
  Absence
     38 (10.1)    10 (10.5) 0.910
Underlying disease 0.013
   Pulmonary disease   13   7
   Diabetes mellitus   63 18
   Hypertension   91 32
   Hepatitis     7   0
   Cerebrovascular 
     accident
    7   2
   Heart disease   12   6
   Total
a) 193 
(152, 40.5%)
65 
(52, 54.7%)
Preoperative symptoms 0.161
   Discomfort, 
     fullness
    49 (13.1)     15 (15.8)
   Pain   115 (30.7)     22 (23.2)
   Dysphagia     5 (1.3)     2 (2.1)
   Indigestion   21 (5.6)     12 (12.6)
   Bleeding   18 (4.8)     7 (7.4)
   Others   28 (7.5)     5 (5.3)
   Total   236 (62.9)     63 (66.3)
Synchronous 
  metastasis (total)
    8 (2.1)     1 (1.1) 0.694
Method of operation 0.233
   Subtotal 
     gastrectomy
  304 (81.1)     82 (86.3)
   Total gastrectomy     71 (18.9)     13 (13.7)
Curability 0.134
   Curative resection   355 (94.7)     86 (90.5)
   Palliative resection   20 (5.3)     9 (9.5)
Postoperative 
  hospital stay (day)
12.0 
(9.0-18.0)
12.0 
(10.0-18.0)
0.940
Values are presented as median (range) or number (%).
a)Values are presented as no. of complicated cases (no. of 
complicated patients, %).
Table 1. Characteristics of patients undergoing resection
Variable
65 ＜ Age (yr) ＜ 74
(n = 375)
75 ≤ Age (yr)
(n = 95)
P-value
Tumor location 0.335
Upper third  60 (16.0)   9 (9.5)
Middle third  97 (25.9) 24 (25.3)
Lower third 215 (57.3) 61 (64.2)
Entire    3 (0.8)   1 (1.1)
Tumor diameter (cm) 0.181
<5.0 225 (60.0) 49 (51.6)
≥5.0, <10.0 130 (34.7) 37 (38.9)
≥10.0  20 (5.3)   9 (9.5)
Depth of invasion 0.026
T1 189 (50.4) 34 (35.8)
T2  78 (20.8) 21 (21.2)
T3 100 (26.7) 39 (41.1)
T4    8 (2.1)   1 (1.1)
Histological type 0.743
Differentiated 226 (60.3) 59 (62.1)
Undifferentiated 149 (39.7) 36 (37.9)
Lymph node metastasis 0.024
N0 221 (58.9) 40 (42.1)
N1  87 (23.2) 28 (29.5)
N2  35 (9.3) 15 (15.8)
N3  32 (8.5) 12 (12.6)
Lymphatic invasion 0.396
Presence
Absence
102 (27.2)
273 (72.8)
30 (31.6)
65 (68.4)
Venous invasion 0.086
Presence
Absence
 24 (6.4)
351 (93.6)
11 (11.6)
84 (88.4)
Lymph node dissection 0.018
D2 197 (52.5) 37 (38.9)
D3 178 (47.5) 58 (61.1)
Stage 0.022
IA 175 (46.7) 29 (30.5)
IB  39 (10.4) 11 (11.6)
II  56 (14.9) 16 (16.8)
IIIA  49 (13.1) 13 (13.7)
IIIB  21 (5.6) 13 (13.7)
IV  35 (9.3) 13 (13.7)
Values are presented as number (%).
Application of 1997 Union for International Cancer Control/ 
American Joint Committee on Cancer 6th tumor-node-metastasis 
classification.
Table 2. Pathological results
frequent than T1, N0, IA in very elderly patients. In the 
method of operation, the ratio of operation type did not 
differ between subtotal gastrectomy and total gastrec-
tomy (P = 0.233), but lymph node dissection of D3 was sig-
nificantly more frequent in very elderly patients (P = 
0.018). Among the underlying diseases of the two age 
groups (very elderly patients, 65 cases and 52 patients; 
young-old patients, 193 cases and 152 patients), hyper-
tension was the most frequent, followed by diabetes melli-
tus, and pulmonary disease (P = 0.013). However, in the 
preoperative symptoms of the two age groups, abdominal 
pain was most frequent, followed by fullness, but the dif-
ference was not significant. Sung Ryol Lee, et al.
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65 ＜ Age (yr) ＜ 74
(n = 375)
75 ≤ Age (yr)
(n = 95)
P-value
Leakage 7 (1.9)   4 (4.2) 0.177
Stricture of 
  anastomosis
8 (2.1)   1 (1.1) 0.492
Bleeding 1 (0.3)   3 (3.2) 0.006
Obstruction 9 (2.4)   0 (0) 0.127
Ascites 5 (1.3)   0 (0) 0.258
Pulmonary 7 (1.9)   2 (2.1) 0.880
Wound infection 7 (1.9)   1 (1.1) 0.584
Other 3 (0.8)   0 (0) 0.382
Total 47 (12.5) 11 (11.5) 0.127
Death within
  30 days
2 (0.5)   1 (1.0) -
Values are presented as number (%).
Table 3. Postoperative morbidity and mortality
Fig. 1. Survival of very elderly patients (≥75 years) and younger 
elderly patients (65 to 74 years) after curative resection. There were 
significant differences in overall survival between the two age 
groups (P = 0.021).
Fig. 2. Survival of very elderly patients (≥75 years) and younger 
elderly patients (65 to 74 years) after palliative resection. There was 
no significant difference in overall survival between the two age 
groups (P = 0.063).
Among all registered patients, postoperative complica-
tions were observed in 58 patients (12.3%)  (11.5% of very 
elderly vs. 12.5% of young-old patients, P = 0.127). The in-
cidence of bleeding was significantly higher in very eld-
erly compared to young-old patients. However, there was 
no significant difference for other complications (Table 3). 
Postoperative mortality was observed in 3 patients (0.6%) 
(1.0% of very elderly patients vs. 0.5% in young-old pa-
tients) but the difference was not significant. 
Among the resected patients, there was a significant dif-
ference in overall survival (OS) rate between two groups 
(5-year survival, 55.9% vs. 73.5% respectively; P = 0.006). In 
addition, among the curatively resected patients, there 
was a significant difference in OS between two groups 
(5-year survival, 61.5% vs. 76.5% respectively; P = 0.021) 
(Fig. 1). However, among the palliatively resected pa-
tients, there was no significant difference in OS between 
two groups (2-year survival, 0.0% vs. 20.0% respectively; P 
= 0.063) (Fig. 2).
OS rates in the patients who underwent curative gas-
trectomy according to clinicopathological variables are 
presented in Table 4. There were significant differences be-
tween two groups in 5-year survival rate; sex, tumor loca-
tion, histological type, depth of invasion, lymphatic in-
vasion, and venous invasion. For each of these variables, 
the 5-year survival rate was significantly worse in very 
elderly patients. In patients receiving curative gas-
trectomy, the OS rate was significantly worse among the 
very elderly than among the young-old patients for stages 
IIIB (P = 0.042) and IV (P = 0.019) (Table 4). However, OS 
rates for stage I, II, IIIA did not differ significantly between 
the two age groups.
In very elderly patients receiving curative gastrectomy, 
histological undifferentiated type, depth of invasion, 
lymph node metastasis, and lymphatic invasion sig-
nificantly affected prognosis according to univariate anal-
ysis, and lymph node metastasis independently influ-
enced prognosis according to multivariate analysis (Table 
5). In young-old patients receiving curative gastrectomy, 
the location of the tumor, tumor diameter, depth of in-
vasion, lymph node metastasis, and lymphatic invasion Gastric cancer in very elderly patients
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Variable
65 ＜ Age (yr) ＜  74
(n = 355)
5-year 
survival (%)
75 ≤  Age (yr)
(n = 86)
5-year 
survival (%)
P-value
Gender
Male 76.1 73.1 0.371
Female 77.5 50.6 0.008
Location of tumor
Upper third 67.7 80.0 0.739
Middle third 80.1 66.3 0.155
Lower third 77.7 59.3 0.021
Entire 50.0 - -
Tumor diameter (cm)
<50 81.4 71.0 0.138
≥50, <100 69.3 50.5 0.051
≥100 63.8 75.0 0.671
Histological type
Differentiated 79.6 72.8 0.212
Undifferentiated 71.9 40.5 0.008
Depth of invasion
T1 91.1 85.5 0.252
T2 63.9 70.9 0.665
T3 57.3 27.8 0.008
T4 75.0 - -
Lymph node metastasis
pN0 86.4 82.2 0.316
pN1 73.6 72.8 0.474
pN2 37.9 13.8 0.082
pN3 18.6 0.00 0.052
Lymphatic invasion
Absence 79.8 73.0 0.183
Presence 66.0 0.0 0.000
Venous invasion
Absence 76.8 63.1 0.035
Presence 72.8 61.7 0.298
Stage
IA 90.4 88.5 0.411
IB 79.8 59.3 0.216
II 68.7 70.7 0.549
IIIA 70.6 79.5 0.722
IIIB 23.6 0.0 0.042
IV 24.9 0.0 0.019
Lymph node dissection
D2 78.5 74.5 0.347
D3 74.6 51.6 0.014
Application of 1997 Union for International Cancer Control/ 
American Joint Committee on Cancer 6th tumor-node-metastasis 
classification.
Table 4. Five-year survival rates according to clinicopathological 
variables in patients undergoing curative resection
significantly affected the prognosis according to uni-
variate analysis, and depth of invasion and lymph node 
metastasis independently influenced prognosis in this pa-
tient group by multivariate analysis (Table 6).
DISCUSSION
Average life expectancy in Korea has progressively in-
creased because of better living conditions, increased con-
sumption of nutritious foods including fruits and vegeta-
bles, and improved treatment of comorbidities and other 
diseases [9,10]. The incidence of gastric cancer as well as 
other cancers has increased in elderly patients. Moreover, 
the increased age of the population is accompanied by an 
increase in age-related diseases. Preoperative surgical risk 
is often higher in elderly patients than young patients 
[11-13]. Therefore it is important to develop therapeutic 
strategies for elderly patients with gastric cancer. 
The average age of gastric cancer patients in this study 
is 70.5 ± 4.6 years. In the present study, elderly patients 
were divided into two groups, a young-old group and a 
very elderly group. The definition of very elderly patients 
(age of 75 years or above) used in this study was suitable to 
obtain a sufficient sample size to attain statistical signi-
ficance.
In the present study, very elderly patients show distinc-
tive characteristics including higher ratio of female gender 
and more frequent underlying disease than young-old 
patients. Finding of more frequent underlying disease is 
consistent with those findings of other report [11]. Howev-
er, the ratio of females is not consistent with the results of 
other reports [14,15]. Other reports showed that female 
had a lower ratio in old age (Young age male:female vs. old 
age is approximately 1:1 vs. 2:1 or 2:1 vs. 2:1) than this pres-
ent study (approximately 2:1 vs. 1:1).
Generally, differentiated type of gastric carcinoma lo-
cated in the lower third of the stomach in the elderly origi-
nates from intestinal metaplasia because of atrophic gas-
tritis induced by exogenous factors [16], or from 
Helicobacter pylori infection [17,18]. In pathological results, 
the tumor is most frequently located in the lower third and 
histological differentiated type is dominant without a sig-
nificant difference in both age groups. The results ob-
tained in the present study are compatible with these pre-
vious observations [16-18]. However, there were sig-Sung Ryol Lee, et al.
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Variable
Univariate analysis hazard ratio 
(95% confidence interval)
P-value
Multivariate analysis hazard ratio 
(95% confidence interval)
P-value
Gender 0.081 0.197
Female/male 0.498 (0.227-1.091) 1.805 (0.736-4.430)
Location of tumor 0.731
Middle/upper 1.490 (0.185-11.979)
Lower/upper 1.084 (0.141-8.315)
Entire/upper                -
Tumor diameter (cm) 0.245 0.910
≥50, ＜100/＜50 1.876 (0.859-1.098) 0.803 (0.282-2.292)
≥100/＜50 2.574 (0.320-20.690) 0.731 (0.064-8.341)
Histological type 0.011
Undifferentiated/
  differentiated
2.694 (1.249-5.809)
Depth of invasion 0.002 0.445
T2/T1 1.185 (0.333-4.213) 0.966 (0.176-5.312)
T3/T1 5.186 (2.023-13.292) 2.567 (0.478-13.777)
T4/T1 0.000 (0.000-) 0.000 (0.000-)
Lymph node metastasis 0.000 0.046
pN1/NO 1.659 (0.555-4.959) 1.184 (0.288-4.868)
pN2/NO 8.160 (2.966-22.445) 4.832 (0.986-23.674)
pN3/NO 18.051 (5.069-64.278) 7.289 (1.078-49.282)
Lymphatic invasion 0.002 0.970
Presence/absence 4.002 (1.649-9.715) 0.972 (0.226-4.175)
Venous invasion 0.146 0.666
Presence/absence 2.546 (0.723-8.959) 1.278 (0.420-3.891)
Stage 0.000
IB/IA 1.279 (0.245-6.662)
II/IA 1.615 (0.432-6.036)
IIIA/IA 1.228 (0.236-6.393)
IIIB/IA 16.365 (4.724-56.691)
IV/IA 25.063 (5.956-105.469)
Lymph node dissection 0.410
D3/D2 1.390 (0.635-3.044)
Application of 1997 Union for International Cancer Control/American Joint Committee on Cancer 6th tumor-node-metastasis classification.
Table 5. Cox proportional hazards regression model in patients ≥75 years of age undergoing curative resection
nificant differences in the depth of invasion and lymph 
node metastasis between the two groups. Very elderly pa-
tients had deeper invasion and more advanced lymph 
node metastases than young-old patients (P = 0.024). 
Previous studies reported that 51% and 45% of elderly pa-
tients had stage III-IV gastric cancer and that there were no 
significant differences between the two age groups 
(around 80 or 75 years old, respectively) [19,20]. However, 
in the present study, although very elderly patients had a 
similar ratio (41.1%) of stage III and IV as previous studies, 
there are significant differences between the two groups. 
Very elderly patients had more advanced gastric cancer in 
ratio than young-old patients. The main reason for the 
poor prognosis in very elderly patients was the low pro-
portion of early stage tumors and the high proportion of 
advanced stage tumors with statistical significance (P = 
0.022). This may be related to the tendency to ignore pre-
operative symptoms and low rates of medical screening 
by endoscopic examination in very elderly patients 
[21-23].    
Although D3 lymph node dissection was more frequent 
in very elderly patients with a similar ratio of method of 
operation and curability (R0), the incidence of total post-
operative morbidity, mortality and postoperative hospital 
stay did not show a significant difference. In patients re-
ceiving D3 lymph node dissection, very elderly patients Gastric cancer in very elderly patients
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Variable
Univariate analysis
hazard ratio (95% CI)
P-value
Multivariate analysis
hazard ration (95% CI)
P-value
Gender 0.720 0.994
Female/male 0.914 (0.559-1.4960) 0.998 (0.600-1.661)
Location of tumor 0.020
Middle/upper 0.529 (0.275-1.017)
Lower/upper 0.502 (0.286-0.881)
Entire/upper 4.261 (0.555-32.708)
Tumor diameter 0.018 0.228
≥50, ＜100/＜50 1.813 (1.130-2.908) 0.586 (0.319-1.080)
≥100/＜50 2.523 (0.990-6.432) 0.698 (0.235-2.071)
Histological type 0.145
Undifferentiated/differentiated 1.406 (0.890-2.222)
Depth of invasion 0.000 0.006
T2/T1 3.551 (1.926-6.547) 3.069 (1.454-6.478)
T3/T1 4.444 (2.485-7.948) 4.153 (1.857-9.291)
T4/T1 2.761 (0.368-20.698) 2.691 (0.316-22.923)
Lymph node metastasis 0.000 0.000
pN1/NO 1.721 (0.965-3.070)
    
1.000 (0.501-1.993)
pN2/NO 5.447 (2.855-10.393) 3.695 (1.652-8.263)
pN3/NO 11.898 (6.004-23.579) 10.129 (3.899-26.315)
Lymphatic invasion 0.003 0.185
Presence/absence 2.055 (1.268-3.329) 0.544 (0.221-1.339)
Venous invasion 0.309 0.620
Presence/absence 1.542 (0.669-3.557) 0.858 (0.468-1.573)
Stage 0.000
IB/IA 1.674 (0.699-4.008)
II/IA 2.597 (1.309-5.153)
IIIA/IA 2.491 (1.200-5.174)
IIIB/IA 9.107 (4.174-19.873)
IV/IA 12.471 (5.971-26.048)
Lymph node dissection 0.148
D3/D2 1.404 (0.886-2.224)
CI, confidence interval.
Table 6. Cox proportional hazards regression model in patients 65 to 74 years of age undergoing curative resection
showed a lower 5-year survival rate compared to young- 
old patients, but it had no effect as a prognostic factor. And 
if a more advanced pattern in very elderly patients is con-
sidered, a low 5-year survival rate is a reasonable result. 
Previous other studies show higher morbidity (29%, 33%) 
and mortality (3%, 8%) than in the present study [19,23]. 
However, the differences were not statistically significant 
in previous other studies, either. Advances in surgical 
techniques, postoperative intensive care, and improved 
performance of very elderly patients contributed to the 
similarity in incidence of surgical morbidity and mortality 
in the two age groups. 
Although prognostic factors were similar in the two 
groups, the overall 5-year survival rate was significantly 
different in the two groups receiving curative gastrec-
tomy. However, when an exhaustive inspection of results 
was carried out, earlier stages (I-IIIA) have no significant 
differences and more advanced stages (IIIB-IV) have sig-
nificant differences in overall 5-year survival rate. In sev-
eral previous studies, the 5-year survival rate was sig-
nificantly different between the two age groups; but when 
the mortality for gastric cancer alone was considered, 
there was no difference [20,24]. However, a Dutch D1-D2 
study reports that the 5-year survival rates of elderly pa-
tients are worse than in people younger than 65 years, not 
only considering all causes of death, but also when death Sung Ryol Lee, et al.
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from gastric cancer is evaluated alone [25]. These con-
stitute limitations of the present study. Additional studies 
would benefit from research into real causes of death and 
comparisons of disease specific survival in the two groups.
In conclusion, very elderly patients can recover from ag-
gressive gastric cancer surgery without increases in post-
operative morbidity and mortality with advanced post-
operative intensive care. The long term survival rates of 
very old patients do not differ from those of young-old pa-
tients, especially in early stage disease (I, II, IIIA). There-
fore, early diagnosis through regular medical screening 
and curative gastrectomy with lymph node dissection 
should be performed in very elderly gastric cancer 
patients.
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